Literature DB >> 8719070

Subacute encephalopathic toxicity of cisplatin.

C Verschraegen1, C A Conrad, W K Hong.   

Abstract

Acute blindness or seizures are usually the first signs of central neurotoxicity from cisplatin. We report a case of subacute neurotoxicity caused by cisplatin. Progressive encephalopathy and partial loss of vision were the main observed signs. This condition was completely reversible upon cisplatin discontinuation, as is usually the case with acute central neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719070     DOI: 10.1016/0169-5002(95)00503-x

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure.

Authors:  Kazufumi Iwata; Hiroshi Watanabe; Takafumi Morisaki; Takanobu Matsuzaki; Takafumi Ohmura; Akinobu Hamada; Hideyuki Saito
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

2.  Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report.

Authors:  Laura L Holman; Yulan Ren; Shannon N Westin
Journal:  BMC Cancer       Date:  2015-10-17       Impact factor: 4.430

3.  Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats.

Authors:  Pei Zhang; Jia-Qing Chen; Wan-Qiu Huang; Wei Li; Yin Huang; Zun-Jian Zhang; Feng-Guo Xu
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

Review 4.  Intracavitary therapies for mesothelioma.

Authors:  C F Verschraegen
Journal:  Curr Treat Options Oncol       Date:  2001-10

5.  Delay of the Blink Reflex in Patients Receiving Platinum-Analogue Chemotherapy.

Authors:  Kang Young Park; Young Sook Park; Yun Hee Park; Hyun Jung Chang; Eun Sol Cho; Seok-Hyun Kim; Woo Jin Kim
Journal:  Ann Rehabil Med       Date:  2016-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.